Found: 72
Select item for more details and to access through your institution.
Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria.
- Published in:
- 2021
- By:
- Publication type:
- journal article
YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-53997-6
- By:
- Publication type:
- Article
Survival benefit and impact of adjuvant therapies following FOLFOX-HAIC-based conversion therapy with unresectable hepatocellular carcinoma: a retrospective cohort study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 16, p. 14761, doi. 10.1007/s00432-023-05243-7
- By:
- Publication type:
- Article
The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 6, p. 2491, doi. 10.1007/s00432-022-04082-2
- By:
- Publication type:
- Article
A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 10, p. 1709, doi. 10.1007/s00432-013-1497-y
- By:
- Publication type:
- Article
Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 12, p. 2041, doi. 10.3390/jpm12122041
- By:
- Publication type:
- Article
Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2021.819985
- By:
- Publication type:
- Article
Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/4835653
- By:
- Publication type:
- Article
Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma.
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/6298502
- By:
- Publication type:
- Article
Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.
- Published in:
- Liver International, 2013, v. 33, n. 4, p. 595, doi. 10.1111/liv.12112
- By:
- Publication type:
- Article
Delineating the molecular landscape of different histopathological growth patterns in colorectal cancer liver metastases.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1045329
- By:
- Publication type:
- Article
42,573 cases of hepatectomy in China: a multicenter retrospective investigation.
- Published in:
- SCIENCE CHINA Life Sciences, 2018, v. 61, n. 6, p. 660, doi. 10.1007/s11427-017-9259-9
- By:
- Publication type:
- Article
ASO Visual Abstract: Comparison between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate/Advanced-Stage Hepatocellular Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 3, p. 2016, doi. 10.1245/s10434-021-10903-4
- By:
- Publication type:
- Article
Correction to: Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 13, p. 5183, doi. 10.1245/s10434-020-08601-8
- By:
- Publication type:
- Article
Changes in hepatitis B virus DNA levels and liver function after transcatheter arterial chemoembolization of hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2011, v. 41, n. 6, p. 553, doi. 10.1111/j.1872-034X.2011.00796.x
- By:
- Publication type:
- Article
Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2021.819985
- By:
- Publication type:
- Article
A Systemic Inflammation Response Score for Prognostic Prediction in Hepatocellular Carcinoma Patients After Hepatectomy.
- Published in:
- Journal of Inflammation Research, 2022, v. 15, p. 6869, doi. 10.2147/JIR.S397375
- By:
- Publication type:
- Article
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919889001
- By:
- Publication type:
- Article
Postoperative Neutrophil-to-Lymphocyte Ratio Change Predicts Survival of Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058184
- By:
- Publication type:
- Article
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials.
- Published in:
- Technology in Cancer Research & Treatment, 2022, p. 1, doi. 10.1177/15330338221117389
- By:
- Publication type:
- Article
Sequential vs. concurrent systemic therapies in combination with FOLFOX-HAIC for locally advanced hepatocellular carcinoma: a single-center, real-world cohort study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12940-0
- By:
- Publication type:
- Article
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.
- Published in:
- Journal of Hepatocellular Carcinoma, 2024, v. 11, p. 463, doi. 10.2147/JHC.S447387
- By:
- Publication type:
- Article
The Prevalence of Irritable Bowel Syndrome after Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Their Association: A Systematic Review and Meta-Analysis of Observational Studies.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 1865, doi. 10.3390/jcm12051865
- By:
- Publication type:
- Article
A Nomogram Based on Preoperative Lab Tests, BMI, ICG-R15, and EHBF for the Prediction of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 1, p. 324, doi. 10.3390/jcm12010324
- By:
- Publication type:
- Article
Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation.
- Published in:
- Cancers, 2018, v. 10, n. 10, p. 378, doi. 10.3390/cancers10100378
- By:
- Publication type:
- Article
Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma.
- Published in:
- Journal of Inflammation Research, 2022, v. 15, p. 5721, doi. 10.2147/JIR.S385921
- By:
- Publication type:
- Article
Transarterial Infusion Chemotherapy with FOLFOX Could be an Effective and Safe Treatment for Unresectable Intrahepatic Cholangiocarcinoma.
- Published in:
- Journal of Oncology, 2022, p. 1, doi. 10.1155/2022/2724476
- By:
- Publication type:
- Article
Preparation of carbon-coated iron nanofluid and its application in radiofrequency ablation.
- Published in:
- Journal of Biomedical Materials Research, Part B: Applied Biomaterials, 2015, v. 103, n. 4, p. 908, doi. 10.1002/jbm.b.33275
- By:
- Publication type:
- Article
Family history of hepatocellulcar carcinoma is not associated with its patients' prognosis after hepatectomy.
- Published in:
- World Journal of Surgical Oncology, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1477-7819-11-280
- By:
- Publication type:
- Article
One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma.
- Published in:
- BMC Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12916-022-02608-6
- By:
- Publication type:
- Article
One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10630-x
- By:
- Publication type:
- Article
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.
- Published in:
- Liver International, 2015, v. 35, n. 9, p. 2155, doi. 10.1111/liv.12818
- By:
- Publication type:
- Article
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition).
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 6, p. 511, doi. 10.1159/000526038
- By:
- Publication type:
- Article
Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 3, p. 192, doi. 10.1159/000521596
- By:
- Publication type:
- Article
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 6, p. 682, doi. 10.1159/000509424
- By:
- Publication type:
- Article
Predictive factors for the benefit of triple‐drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 9, p. 4200, doi. 10.1002/cam4.2355
- By:
- Publication type:
- Article
A novel inflammation‐based nomogram system to predict survival of patients with hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 10, p. 5027, doi. 10.1002/cam4.1787
- By:
- Publication type:
- Article
Association of Virological Response to Antiviral Therapy With Survival in Intermediate-Stage Hepatitis B Virus-Related Hepatocellular Carcinoma After Chemoembolization.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.751777
- By:
- Publication type:
- Article
Usp14 deficiency removes α-synuclein by regulating S100A8/A9 in Parkinson's disease.
- Published in:
- Cellular & Molecular Life Sciences, 2024, v. 81, n. 1, p. 1, doi. 10.1007/s00018-024-05246-8
- By:
- Publication type:
- Article
Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients.
- Published in:
- BMC Cancer, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12885-021-08428-w
- By:
- Publication type:
- Article
Risk of hepatitis B virus reactivation and its effect on survival in advanced hepatocellular carcinoma patients treated with hepatic arterial infusion chemotherapy and lenvatinib plus programmed death receptor-1 inhibitors.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 1, doi. 10.3389/fcimb.2024.1336619
- By:
- Publication type:
- Article
Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/v14040656
- By:
- Publication type:
- Article
Development and validation of robust metabolism‐related gene signature in the prognostic prediction of hepatocellular carcinoma.
- Published in:
- Journal of Cellular & Molecular Medicine, 2023, v. 27, n. 7, p. 1006, doi. 10.1111/jcmm.17718
- By:
- Publication type:
- Article
The Optimal Management for Sub-Centimeter Hepatocellular Carcinoma: Curative Treatments or Follow-Up?
- Published in:
- Medical Science Monitor, 2019, v. 25, p. 4941, doi. 10.12659/MSM.916451
- By:
- Publication type:
- Article
YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8<sup>+</sup> T cell recruitment.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02097-6
- By:
- Publication type:
- Article
Novel percutaneous radiofrequency ablation of portal vein tumor thrombus: safety and feasibility.
- Published in:
- 2013
- By:
- Publication type:
- journal article